The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenemia
Lai KN, Jam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenemia. Nephron 1990; 54: 12-17
Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa
Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Bisceglie AMD. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995; 109: 540-546
Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations
Johnson RG, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990; 37: 663-676
Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen
Knecht GL, Chisari FV. Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen. Gastroenterology 1978; 75: 1152-1156
Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon
Chung DR, Yang WS, Kim SB et al. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 1997; 17: 112-117